{"id":"NCT02321462","sponsor":"Ipsen","briefTitle":"Efficacy, Safety and Tolerability of Eziclen in Adult Subjects Undergoing Colonoscopy","officialTitle":"Efficacy, Safety and Tolerability of a Split-dose of a New Bowel Cleansing Preparation (Eziclen) in Adult Subjects Undergoing Colonoscopy: A Phase III, Multicentre, Randomised, 2 Parallel Group, Comparative Versus Fortrans®, Non-inferiority, Investigator-blinded Study","status":"COMPLETED","phase":"PHASE3","dates":{"start":"2015-03","primaryCompletion":"2015-12","completion":"2015-12","firstPosted":"2014-12-22","resultsPosted":"2019-02-27","lastUpdate":"2019-03-04"},"enrollment":296,"design":{"allocation":"RANDOMIZED","model":"PARALLEL","masking":"SINGLE","primaryPurpose":"DIAGNOSTIC"},"conditions":["Bowel Cleansing"],"interventions":[{"type":"DRUG","name":"Eziclen","otherNames":[]},{"type":"DRUG","name":"Fortrans®","otherNames":[]}],"arms":[{"label":"Eziclen","type":"EXPERIMENTAL"},{"label":"Fortrans®","type":"ACTIVE_COMPARATOR"}],"summary":"The purpose of this study is to demonstrate that Eziclen is non-inferior to Fortrans® (the reference colonic lavage in Russia) administered in adult subjects scheduled to undergo colonoscopy for a routinely accepted diagnostic indication.","primaryOutcome":{"measure":"Adjusted Percentage of Patients With Successful Overall Colon Preparation, Assessed by the Global Score of the Boston Bowel Preparation Scale (BBPS).","timeFrame":"Colonoscopy was performed on Day 2.","effectByArm":[{"arm":"Eziclen","deltaMin":97.18,"sd":null},{"arm":"Fortrans®","deltaMin":97.65,"sd":null}],"pValues":[{"comp":"OG000 vs OG001","p":null}]},"eligibility":{"minAge":"18 Years","sex":"ALL","healthyVolunteers":false,"inclusionCount":4,"exclusionCount":26},"locations":{"siteCount":3,"countries":["Russia"]},"refs":{"pmids":[],"seeAlso":[]},"adverseEventsSummary":{"seriousAny":{"events":1,"n":147},"commonTop":["Nausea","Abdominal distension","Hyperuricaemia","Abdominal discomfort","Abdominal pain"]}}